The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.
about
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiamTOR inhibitors effects on regulatory T cells and on dendritic cellsFunctional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosisImmune regulation of human herpesviruses and its implications for human transplantationVaccine applications of flow cytometryFunctional Significance of CD57 Expression on Human NK Cells and Relevance to DiseaseImmunosenescence in renal transplantation: a changing balance of innate and adaptive immunityAmiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cellsNumerical and functional defects in CD8+ CD28- T-suppressor lymphocytes from patients with primary immune thrombocytopenia.Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionPerforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.Human CD8+ CD57- TEMRA cells: Too young to be called "old"Predominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection.Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection.Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunctionGood cell, bad cell: flow cytometry reveals T-cell subsets important in HIV diseaseClonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivoStepwise maturation of lytic granules during differentiation and activation of human CD8+ T lymphocytes.Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.Specific expression of GPR56 by human cytotoxic lymphocytes.Monoclonal TCR-redirected tumor cell killing.CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome.Coordinated regulation of NK receptor expression in the maturing human immune system.The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by ageEpitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasisIncreased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.Age-related deregulation of naive T cell homeostasis in elderly humansA recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.Immune signature of tumor infiltrating immune cells in renal cancer.HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosisCharacterization of an effective CTL response against HIV and SIV infections.
P2860
Q24632975-766790F4-AD2A-48A1-8F20-E14FFDF90E3FQ26744447-DBC088A5-6FD2-4BF7-AE2F-C56574BAF5CBQ26849399-59320671-D94D-429D-AD78-75086D33AAA1Q26992146-9DE5F3B6-A1A2-4EEC-B37D-1474FDECA66FQ27004341-98DEFAD2-8994-4759-9975-E967A8B48523Q27022458-30D9444A-CFC1-4B74-B34E-B526DAEDE59FQ28084018-A2A94151-2E5D-4042-9A2C-433E6BE736A9Q28481556-578D4E55-F7F7-45C7-B4AF-EDDDBDA6764BQ33441562-C8A18554-44A6-4D12-AC26-EB7C43282873Q33479167-A5F91753-1DEE-487E-A9B4-F81718C3176AQ33594461-069D61C1-28BA-43A3-880B-18FE54B6E1A9Q33624846-134F2C63-2ECA-498E-B91E-A251EC1B3781Q33648329-9B2D05B9-F229-4C4C-A3F5-F56D8D900336Q33653526-BF6E0FB7-1AA0-482F-819E-7D4CE65A332CQ33654658-8478858B-C962-407C-AF40-4DC6F2D89A0BQ33769360-66719189-2C21-4DAA-8A37-7046ECA75F6EQ33903742-CE88E815-67B5-404C-890B-776B9A80A7BAQ33927135-B08FB452-7208-4D6D-9450-35B985DC8802Q33974650-560F07F4-4B73-4D3B-AE15-589E75F5DFC0Q34007172-E6A37AA4-90C5-45F5-891B-927B31DC7F1FQ34033884-6E90581D-EC2A-4478-9A77-EE2D8883B53FQ34071769-82275586-7C42-4FDF-9BE9-972399298466Q34079261-3BDCB003-AA5B-4AEA-983E-35E18559B0CDQ34197122-D1CC8F72-6482-4361-AA82-7566C5DA9807Q34273053-B8BF2104-999F-40C2-B78F-4C84BA4A320FQ34310907-37A36366-E843-43F1-85DB-871E71C61DD0Q34338725-FC341D35-1812-4217-ABB2-48D7BE66F57BQ34463050-78013342-DA58-464C-97DC-C65FD7398E53Q34476273-8AF67C35-0672-4285-ADF3-7D1D5DD96D03Q34524651-68B1A25A-2289-4A84-AAF8-6DD3EF25B438Q34548297-F9EC6144-E49E-4679-AB7B-BA959DCBAEDEQ34611308-FBE114F4-6029-4AB6-BBAD-A76EB4F568E5Q34870550-4A33702D-F304-4361-B7F4-A3E54E1C191BQ35021753-9115EDAF-5767-48BA-A18C-B583C11E6673Q35080234-DEC3C3DC-59F8-4AB6-A533-066A1EE6CC81Q35121627-75160278-07B3-4B1E-B8B6-7DF52C1D2F99Q35201895-4392A63E-62DD-472D-9D90-7A3D6A373018Q35234257-F754C83C-07CE-4C07-847B-26681989C3C7Q35249154-8B8DA5D2-9990-4272-AB37-2F0CB4042E24Q35250925-03314CF0-A6CA-4833-B21C-77183ACEA0D0
P2860
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@en
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@nl
type
label
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@en
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@nl
prefLabel
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@en
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@nl
P2093
P2860
P356
P1476
The cytolytic enzymes granyzme ...... ty and bright CD57 expression.
@en
P2093
Emma Gostick
Helen Horton
Mario Roederer
Michael R Betts
Stephen C De Rosa
P2860
P356
10.1189/JLB.0208107
P577
2008-10-10T00:00:00Z